MK-677 blood sugar claims: what the evidence actually shows

What's this video probably claiming?

Based on the caption, @enhancedrob is walking viewers through the downsides of MK-677 (ibutamoren), then immediately selling them a solution. The pitch goes like this: yes, MK-677 raises blood sugar, but a product called Slin pills will neutralize that problem, and Shredz XT will handle the water retention. The creator drops affiliate codes for two supplement companies in the same breath. This is a classic harm-minimization sales format that's been spreading across fitness TikTok for two years. The implicit message is that MK-677's known metabolic risks are manageable consumer problems, not clinical concerns requiring medical oversight. That framing deserves serious scrutiny, because it collapses a genuinely complex endocrine issue into a supplement stack recommendation for an audience that skews young and self-experimenting.

What does the science actually show?

MK-677 is a ghrelin receptor agonist that stimulates pulsatile growth hormone secretion. In a 2-year randomized controlled trial by Nass et al. (2008, Annals of Internal Medicine), 65-year-old adults receiving 25mg daily showed significant increases in IGF-1 but also meaningful increases in fasting glucose and insulin resistance. Roughly 18% of subjects developed blood glucose levels consistent with impaired fasting glucose during the trial. A shorter study by Svensson et al. (1998, Journal of Clinical Endocrinology and Metabolism) confirmed that even single-dose administration at 25mg produced measurable insulin resistance within hours. The mechanism is understood: elevated GH suppresses insulin-mediated glucose uptake in peripheral tissues. This is not a fringe side effect, it is a pharmacologically predictable outcome of the drug's mechanism of action. No supplement company product has been tested in a randomized trial against MK-677-induced insulin resistance.

Where does the social media noise diverge from clinical reality?

The Slin pills claim is where this video moves from opinion into territory that requires a hard flag. "Slin" products are typically berberine-based or contain ingredients like chromium, alpha-lipoic acid, and cinnamon extract marketed as insulin sensitizers. Berberine has legitimate small-trial evidence for modest glucose-lowering effects, roughly comparable to low-dose metformin in one meta-analysis by Dong et al. (2012, Evidence-Based Complementary and Alternative Medicine). But that evidence base involves people with type 2 diabetes or prediabetes, not people with drug-induced GH excess artificially suppressing insulin signaling. Extrapolating from one context to the other is not supported by any published data. More directly: telling 5,600 viewers they "do not have to worry" about blood sugar while using a pharmacologically active secretagogue is a claim that no clinical evidence supports. It creates false safety assurance around a compound that has no FDA approval for any indication in healthy adults.

What should you actually know?

MK-677 is not approved by the FDA. It was investigated by Merck and Novo Nordisk in the 1990s and 2000s for muscle wasting and growth hormone deficiency, and those programs did not result in approved drugs. It is currently classified by the FDA as an investigational new drug, meaning it cannot legally be sold as a supplement in the United States. Purchasing it through third-party research chemical sites carries real legal and safety risk. The blood glucose effect is real, dose-dependent, and not reliably offset by any over-the-counter supplement product. Water retention from MK-677 is also well-documented, driven by elevated IGF-1 and aldosterone activity, and a fat-burner supplement has not been studied as a countermeasure. If you are considering GH-axis therapies for documented deficiency, that conversation belongs with an endocrinologist who can monitor IGF-1, fasting glucose, and HbA1c, not a TikTok affiliate code.